Genomics BioSci & Tech. Co.,Ltd. (TPEX: 4195)
Taiwan
· Delayed Price · Currency is TWD 19.20
+0.10 (0.52%)
Dec 31, 2024, 3:00 PM CST
Genomics BioSci & Tech. Co.,Ltd. Revenue
Genomics BioSci & Tech. Co.,Ltd. had revenue of 212.59M TWD in the half year ending June 30, 2024, with 3.59% growth. This brings the company's revenue in the last twelve months to 417.04M, up 2.85% year-over-year. In the year 2023, Genomics BioSci & Tech. Co.,Ltd. had annual revenue of 396.14M, down -5.46%.
Revenue (ttm)
417.04M
Revenue Growth
+2.85%
P/S Ratio
3.33
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 396.14M | -22.86M | -5.46% |
| Dec 31, 2022 | 419.00M | 29.04M | 7.45% |
| Dec 31, 2021 | 389.97M | -53.21M | -12.01% |
| Dec 31, 2020 | 443.18M | 15.52M | 3.63% |
| Dec 31, 2019 | 427.65M | 52.26M | 13.92% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 8.32B |
| Lotus Pharmaceutical | 17.59B |
| Oneness Biotech | 112.20M |
| Lumosa Therapeutics | 37.82M |
| Polaris Group | 75.65M |
| Center Laboratories | 1.57B |
| Pegavision | 7.06B |
| TaiMed Biologics | 622.61M |